These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11206046)

  • 1. Screening for detection of new antidepressants, neuroleptics, hypnotics, and their metabolites in urine by GC-MS developed using rat liver microsomes.
    Bickeboeller-Friedrich J; Maurer HH
    Ther Drug Monit; 2001 Feb; 23(1):61-70. PubMed ID: 11206046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn.
    Meyer GM; Maurer HH
    Anal Bioanal Chem; 2013 Dec; 405(30):9779-89. PubMed ID: 24141317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHPLC-MS/MS and UHPLC-HRMS identification of zolpidem and zopiclone main urinary metabolites and method development for their toxicological determination.
    Strano Rossi S; Anzillotti L; Castrignanò E; Frison G; Zancanaro F; Chiarotti M
    Drug Test Anal; 2014 Mar; 6(3):226-33. PubMed ID: 23512850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry.
    Maurer HH; Bickeboeller-Friedrich J
    J Anal Toxicol; 2000; 24(5):340-7. PubMed ID: 10926357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
    Meyer MR; Vollmar C; Schwaninger AE; Wolf E; Maurer HH
    J Mass Spectrom; 2012 Feb; 47(2):253-62. PubMed ID: 22359337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants.
    Wissenbach DK; Meyer MR; Remane D; Weber AA; Maurer HH
    Anal Bioanal Chem; 2011 Apr; 400(1):79-88. PubMed ID: 21079926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
    Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
    Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
    Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
    Staack RF; Maurer HH
    J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
    Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening procedure for detection of phenothiazine and analogous neuroleptics and their metabolites in urine using a computerized gas chromatographic-mass spectrometric technique.
    Maurer H; Pfleger K
    J Chromatogr; 1984 Mar; 306():125-45. PubMed ID: 6143762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and differentiation of barbiturates, other sedative-hypnotics and their metabolites in urine integrated in a general screening procedure using computerized gas chromatography-mass spectrometry.
    Maurer HH
    J Chromatogr; 1990 Sep; 530(2):307-26. PubMed ID: 2079506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration.
    Lehner AF; Hughes CG; Harkins JD; Nickerson C; Mollett B; Dirikolu L; Bosken J; Camargo F; Boyles J; Troppmann A; Karpiesiuk WW; Woods WE; Tobin T
    J Anal Toxicol; 2004; 28(4):226-38. PubMed ID: 15189672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
    Kratzsch C; Peters FT; Kraemer T; Weber AA; Maurer HH
    J Mass Spectrom; 2003 Mar; 38(3):283-95. PubMed ID: 12644990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening procedure for detection of antidepressants and their metabolites in urine using a computerized gas chromatographic--mass spectrometric technique.
    Maurer H; Pfleger K
    J Chromatogr; 1984 Feb; 305(2):309-23. PubMed ID: 6549607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
    Welter J; Meyer MR; Kavanagh P; Maurer HH
    Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.
    Beyer J; Bierl A; Peters FT; Maurer HH
    Ther Drug Monit; 2005 Aug; 27(4):509-20. PubMed ID: 16044110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation.
    Beyer J; Peters FT; Maurer HH
    Ther Drug Monit; 2005 Apr; 27(2):151-7. PubMed ID: 15795644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Arlt JW
    J Anal Toxicol; 1999; 23(2):73-80. PubMed ID: 10192408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.